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Brief Report
Diagnosing the Tight Building Syndrome
by Sherry A. Rogers*
Formaldehyde is but one of many chemicals capable of causing the tight building syndrome or envi-
ronmentally induced illness (EI). The spectrum of symptoms it may induce includes attacks ofheadache,
flushing, laryngitis, dizziness, nausea, extreme weakness, arthralgia, unwarranteddepression, dysphonia,
exhaustion, inability to think clearly, arrhythmia or muscle spasms. The nonspecificity ofsuch symptoms
can baffle physicians from many specialties. Presented herein is a simple office method for demonstrating
that formaldehyde is among the etiologic agents triggering these symptoms. The very symptoms that
patients complain of can be provoked within minutes, and subsequently abolished, with an intradermal
injection ofthe appropriate strength offormaldehyde. This injection aids in convincing the patient ofthe
cause of the symptoms so he can initiate measures to bring his disease under control.
Introduction
A surveyoftheliterature indicates homeswithindoor
chemical problems have higher concentrations of vola-
tile organic compounds than houses without problems
(1). The tight building syndrome is defined as a building
in which worker complaints ofill health are more com-
mon than might be reasonably expected (2). Further-
more, it is assumed that nonoccupational explanations
ofsymptoms have been ruled out. Some have called this
illness in victims of the tight building the sick building
syndrome (3), but medical specialists relate better to
the treatment of people.
Over 25 years ago, Randolph (4) recognized that
chemicals in the indoor air environment could provoke
symptoms, but acceptance was delayed by lack of mea-
surements and testing techniques which today abound.
Because manyofthese indoorchemicals existin outdoor
air as well, a more accurate designation might be en-
vironmental illness, or EI.
Volatile organic hydrocarbons are but a part of the
triggers of the tight building syndrome (TBS) or envi-
ronmentally induced illness (EI). With the installation
of urea foam formaldehyde insulation (UFFI), a con-
cordant dramatic increase in symptomatology provided
a vast number of victims for study. This provided us
with a prototype from which we could observe the ev-
olution and diversity of symptoms associated with an
acute increase in one quantifiable indoor chemical, for-
maldehyde.
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Over the last 6 years, increasing numbers ofpatients
have presented with symptoms reminiscent of these
UFFI victims (5), but they had no history of UFFI
exposure (6,7). Measurements of ambient levels of for-
maldehyde have shown that new mobile homes, newly
constructed homes with particleboard subflooring, of-
fices recently renovated with paneling or prefabricated
walls, new clothing, or even new carpeting or new fur-
nishings, and homes with new beds and cabinetry can
accumulate as much formaldehyde, as a result of off-
gassing, as a UFFI home (8-11). A variety of other
commonly encountered volatile substances are capable
of inducing the same symptoms (12-15). For example,
the mean reported levels for formaldehyde in indoor air
in residences was 0.03 ppm for houses without UFFI
and 0.12 ppm for houses with UFFI (with and without
complaints) (11). Some mobile homes had levels of 0.4
ppm, and the mean level for several hospitals was 0.55
ppm.
Guidelines are needed to facilitate diagnosis and iden-
tification ofthe triggering agents. Attacks ofheadache,
nausea, inability to concentrate, mental obtundation,
dizziness, lethargy, arrhythmia, flushing, laryngitis, do-
piness, irritability, dysphonia, unwarranteddepression,
arthralgia, and extreme weakness, although nonspe-
cific, are some ofthe most common symptoms ofEI and
frequently lead to a sequence of diagnostic evaluations
which are ineffective; psychiatric evaluation is often
suggested.
With proper questioning, the victimwill often be able
to associate the onset of disease with the purchase of
new carpeting, furniture, beds, cabinets, renovation ofS. A. ROGERS
the home or office, moving into a new dwelling, or in-
sulating with UFFI. We now need a test that would
substantiate thatformaldehyde (orotherchemicals)was
among the triggers.
Materials and Methods
In this study, U.S.P. 37% reagent grade formalde-
hyde was diluted 50% with Hollister-Stier diluent and
was used as a concentrate. One milliliter of this con-
centrate was added to 4 mL ofsterile water; this made
dilution 1, a 3.7% formaldehyde solution. One milliliter
ofdilution 1 and 4 mL ofdiluent made dilution 2, which
thus was a 0.7% solution. Fivefold serial dilutions as
described by Miller and Morris (16,17) were thus pre-
pared out to dilution 9, a solution containingjust under
106 of 1% formaldehyde (0.0000094%).
Testing of patients, who in all cases had failed to
obtain relief with medical treatments elsewhere, was
initiated with an intradermal injection of 0.01 cc ofthe
dilution 3 (0.15% formaldehyde); this injection resulted
in a 4 mm x 4 mm wheal. After 10 min the symptoms
and wheal size were determined. If no symptoms and
no growth in wheal size were observed, 0.05 cc of di-
lution3wasinjected, resultingina7mm x 7mmwheal.
If after another 10 min both parameters were again
negative, then the test was considered negative. If
either parameter was positive, then 0.05 cc of dilution
4 (0.03% formaldehyde) was tested. If positive, then
0.05 cc of dilution 5 (0.006% formaldehyde) was used.
Negative wheal growth and negative symptoms deter-
mined the point at which testing was terminated. If
symptoms were produced with positive wheal growth
and were subsequentlyeliminated bythe dosethatgave
no wheal growth, the test was considered positive.
Alltests weredone in asingle-blind fashion, and were
preceded by at least one placebo injection of normal
saline for baseline and placebo control. Patients were
never aware ofwhat they were being tested with until
all tests had been completed.
In some cases, the blood serum level of formic acid,
a metabolite of inhaled formaldehyde, was measured
(SmithKline Laboratories, KingofPrussia, PA). In oth-
ers, a 24 hr level offormaldehyde in the ambient air of
a suspect room was measured with a passive (badge)
monitor.
Selected Case Examples
For brevity, only 2 of 24 cases are presented.
C.P. was a 39-year-old consulting engineer who trav-
eled extensively. Two years ago he moved into a new
home in the Syracuse, NY, area. There were new car-
peting and particleboard subflooring throughout the
house. Six months after moving he experienced an in-
sidious onset ofjoint pain. He consulted an internist, a
rheumatologist, and in spite oftheir treatments, he re-
ported a year-and-a-half later that he had the same
symptoms. He also indicated that he ached more after
he had been at home for the weekend, but felt well
whenever he was out to town for a few days.
His blood serum level offormic acid (a metabolite of
formaldehyde) was 10 ,ug/mL after a weekend at home,
and 6 ,tg/mL after a day at work. A passive (badge)
monitor showed an ambient 24-hr formaldehyde level
of0.06 ppm in his home. Note that current recommen-
dations for maximum ambient air formaldehyde expo-
sure levels range from 0.25 ppm (National Academy of
Sciences) to 0.12 ppm (American Society of Heating,
Refrigeration, and Air Conditioning Engineers), while
concentrations below0.06ppmare considered oflimited
or no concern (18).
Single-blind testing with normal saline produced no
symptoms. An injection of 0.01 cc of dilution 3 (0.15%
formaldehyde) produced wheal growth and "a warm
feeling"; 0.05 cc ofdilution 4 (0.03%) produced "ringing
in the ears and achy joints." With a 0.05 cc of dilution
5 (0.006% formaldehyde), after 10 min all of his symp-
toms were clear, and there was no wheal growth. An-
othernormal saline produced no whealgrowth orsymp-
toms.
M.B. was a 41-year-old teacher who had worked in
the same school for 8 years. Over summer vacation,
renovations were done in the school. When she re-en-
tered the building in the fall, she started having symp-
toms that with each subsequent entry came on more
quickly and more severely. She would eventually lose
her voice as it gradually became more hoarse over the
first few hours of work. She also experienced a sore
throat and tender submandibular lymphadenopathy.
She would have a feeling of achiness as though a flu
were starting, and became exhausted. These symptoms
persisted for a day ortwo afterleavingthe building and
were proportional in duration and severity to the
amount oftime she spent there. At home she was with-
out symptoms. Her serum level of formic acid was 10
,ug/mL after a day at school and 6 ,ug/mL after a week-
end at home. This measurement was repeated with the
same results on subsequent days. The 24-hr level of
formaldehyde inthe school air, measured with apassive
(badge) monitor, was 0.06 ppm. Single-blind testing to
formaldehyde duplicated her symptoms in the office,
with administration of 0.05 mL of dilution 5 (0.006%
formaldehyde) producing visible facial flushing and
weakening the patient's voice. The next dose, 0.05 mL
of dilution 6, cleared the symptoms.
All patients described were universally and unques-
tionably freer ofsymptoms afterthey had beenthrough
an intensive educational program to teach them how to
lower their ambient levels offormaldehyde exposures.
Discussion
The last half decade has provided us with over 1000
patients with undiagnosed chronic symptoms, refrac-
tory to a wide variety oftreatments. Single-blind test-
ing to various chemicals generally identified a suspect
chemical and provided convincing enough duplication of
symptoms in patients to enable them to make incon-
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venient and costly environmental changes that appear
to be a necessary part of a comprehensive program to
bringaboutsymptomreliefforthefirsttime. Obviously,
we have extended these techniques to include other
difficult-to-avoid chemicals such as toluene, benzene,
xylene, ethanol, trichloroethylene, natural gas, and
more, and in many instances have paired the intrad-
ermal skin tests with serum measurements before and
after exposure to the suspected environmental xeno-
biotics (tests performed by Enviro-Health Laborato-
ries, Richardson, TX).
Inpatientsrequiringlegalproofofchemicalexposure,
serum levels ofthese chemicals are obtained after a day
at work and another set after a day at home. When the
levels at home are comparatively lower, we have been
able to provoke and duplicate symptoms with the par-
ticular chemical, single blind or double blind, and then
neutralize or terminate symptoms with the nonreacting
intradermal dose in our office, which is exceptionally
free of potential chemical pollutants.
To accomplish a pollutant-free environment in our
office, carpets have been removed and replaced with
hardwood or quarry tile floors. Wooden cabinets and
synthetic chairs have been replaced with metal. As
many extraneous materials as possible are kept out of
the testingroom. Metal lockers are provided in another
area for purses, coats, and packages. No people are
allowed into the office who do not pass the snifftest by
nurses who are sensitive to chemicals. Nurses and all
patients must be free of fragrances, fabric softeners,
polyester clothes, dry-cleaning fluid, cosmetics, toile-
tries, tobacco smoke, home cooking odors, work odors,
and, in fact, any detectable odors. Air depollution de-
vices with charcoal and potassium permanganate filters
to absorb chemicals are used extensively, and outdoor
air is continually filtered and pumped inside.
It is evident that a supersensitive individual cannot
be tested, for example, by a nurse wearing perfume.
He can react to this trigger shortly after coming into
contact with her, confusing the test results. The major
problem is that the treatment dose for the chemical
being tested will not stop his symptoms, because it is
not the chemical that initiated them. This has been re-
peatedly demonstrated and has helped us attain a pro-
gressively less contaminated office and, in particular,
testing area. Many people happily note the relative
paucity of symptoms that they experience after they
have been in our office for a period oftime.
It seems thatmultiple changes inthe immune system
are triggered in part by the increasing environmental
overload (19,20). The mechanism ofthis technique may
involve in part the prostaglandin system (21). Many
have pondered why only one specific dose of the same
agentthat causesthe symptom can also abolish it, while
all other doses trigger the actual symptom or are with-
out effect. Many biological systems have dose-depen-
dent diverse actions. Certainly, we know various bio-
logical responses have a dose that enhances and a dose
of the same substance that suppresses (22). Likewise,
many biological systems have a bell-shaped response
curve wherethere is an optimum dose forresponse, and
doses too high or too low will be ineffective. As well,
nonimmunologic mediatorreleasecan evenbetriggered
by a change in substrate concentration (23).
Two characteristics of environmentally induced ill-
ness are perhaps most worrisome; the phenomena of
spreading and ofheightened sensitivity. Illness inthese
patients was usually triggered by an over exposure to
one chemical, such as formaldehyde; prolonged expo-
sure to the initial stimulus will frequently result in the
development of hypersensitivities to other chemicals,
spreadingtofoods, orinhalantssuchasdustsandmolds.
Furthermore, once sensitized, the patient gradually
reacts with heightened sensitivity to increasingly lower
levels of the insulting agent.
The practitioner dealing with this select patient pop-
ulation is thus presented with a set of diagnostically
baffling symptoms, which, despite accepted medical
treatments, may become worse as weaker and less in-
tense exposures to the initial chemical triggers symp-
toms. All the while, other chemicals and antigens may
become triggers as well.
Formaldehyde exposure can be related to the level
offormic acid measured inthe blood. Formic acid is also
a metabolite of endogneously produced formaldehyde.
Formaldehyde oxidase normally rapidly converts al-
dehydes into acids, since aldehydes are harmful to the
body in promoting cross-linking. But formaldehyde ox-
idase is limited in its production, and with ambient ov-
erload, production is unable to keep up with the in-
creased demand. Once production is exceeded, the bio-
chemistry switches from an oxidation reaction to a re-
duction reaction with alcohol dehydrogenase. This may
explain the preponderance of cerebral or toxic brain
symptoms as the aldehydes are reduced to alcohols (24-
26).
Sincethese reactionsrequire folicacid (27), oftenfolic
acid deficiency was observed, as well. Certainly, as de-
ficiencies progressed with continual exposures, other
biochemical systems would be adversely affected by a
domino effect. This may explain the spreading phenom-
enon whereby other sensitivities develop and other tar-
get organs became involved. It is an interesting obser-
vation that rats cannot get formaldehyde toxicity be-
cause formate does not accumulate in this species.
Hence, the rat would appear to be an invalid animal in
which to do formaldehyde toxicity studies (27).
The diversity ofsymptoms ofEI victims is more eas-
ily appreciated with the understanding ofthe extent of
the damage that is rendered by inhaled xenobiotics or
toxic chemicals. Toxic chemicals interfere with cellular
energy metabolism by inhibiting glycolysis and mito-
chondrial respiration. They inhibit ATP synthesis and
other enzymes, decrease the efficiency of the sodium
pump, disrupt cell membranes, produce free radicals,
overload the cytochrome P-450 detoxication system,
and damage DNA (28). Each person's biochemical
uniqueness serves to amplify the possibilities.
This paper presents a simple method for determining
ifapatientissensitivetoformaldehyde. Wedonotknow
the percentage of sensitivity or accuracy, nor do we
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understand the mechanisms, but in testing over 1000
patients with these baffling symptoms, those reacting
positively have all improved after being shown how to
reduce their environmental chemical overload. Treat-
ments were based on avoidance ofchemicals that were
shown to duplicate symptoms.
One important caution: The testing method will not
work if the physician's office has an ambient level of
formaldehyde or any other triggering agent that pro-
vokes the patient's symptoms. This may explain the
major cause offailure ofclinical investigators who have
tried these techniques and been unable to reproduce
these results. The need to lower the total load or total
burden of chemicals presented to the patient (in his
system and in the test area) is fundamental to the suc-
cess ofthis technique and cannot be overstressed. The
samesubjects, testeddoubleblindtothesamechemicals
in a normal office or hospital, do not respond in a pre-
dictable manner; whereas in an office such as ours,
where special measures have been taken to omit many
commonly occurring chemicals, the technique appears
able to turn symptoms on and off like a switch.
Basic principles used to create a safe testing envi-
ronment are decreasing the amount of synthetic ma-
terials used, markedly increasing the ventilation, and
filtering the air. It is important to reiterate the varia-
bility in sensitivity and target organ of man and the
need to focus attention on the importance ofindoor air
quality on health.
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